Stéphane Barete

11PUBLICATIONS
67CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 07, 2026
MEK inhibition achieves robust and durable responses in Erdheim-Chester disease.

|Sep 29, 2026
Immune-related adverse events with mogamulizumab in cutaneous T-cell lymphoma: A multicentre study.

|Sep 16, 2026
Oral Relapsing Lymphomatoid Papulosis: A Case Report.

|Jun 13, 2025
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score-Matched Controlled Prospective Study.

Adèle de Masson, Marie Beylot-Barry, Caroline Ram-Wolff

|Jan 08, 2025
T cell malignancies after CAR T cell therapy in the DESCAR-T registry.

Remy Dulery, Vincent Guiraud, Sylvain Choquet

|May 24, 2015
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.

Stéphane Barete, Olivier Lortholary, Gandhi Damaj

Pageof 2

Frequent Collaborators

3 joint publications

Roch Houot

3 joint publications

Emmanuel Bachy

2 joint publications

Nicolas Boissel

2 joint publications

Adèle de Masson